A Conversion Study to Assess Safety and Efficacy of a MR4 Based Immunosuppressive Regimen in Stable Liver Recipients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00384202
Recruitment Status : Completed
First Posted : October 5, 2006
Last Update Posted : July 9, 2014
Information provided by:
Astellas Pharma Inc

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : November 2007
  Study Completion Date : November 2007